Clinical Trials Directory

Trials / Completed

CompletedNCT02650583

Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children

Enhancing Connections Program in Palliative Care: Taking Care of the Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication with their children and help them to cope with their parent's incurable cancer.

Detailed description

PRIMARY OBJECTIVES: I. To test the feasibility of the study protocol in advanced cancer patients (recruitment/retention, dosage and fidelity of the intervention; program acceptability of program; and logistics). II. To evaluate the short-term impact of the program on the diagnosed parents' and children's adjustment using a within group design (pre- and post-test design). III. To compare outcomes from the Enhancing Connections Program with outcomes obtained from the completed Phase III trial (between group design). OUTLINE: Patients participate in Enhancing Connections Program comprising of anchoring patients to help their child, adding to listening skills, building on listening skills, being a detective of their child's coping, and celebrating success for 5 sessions. Patients also receive workbook which includes text from the sessions, handouts, and at-home assignments to be completed between sessions.

Conditions

Interventions

TypeNameDescription
OTHEREducational InterventionReceive Enhancing Connections Program
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2015-12-28
Primary completion
2018-02-15
Completion
2018-02-15
First posted
2016-01-08
Last updated
2019-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02650583. Inclusion in this directory is not an endorsement.